Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIPRIM: Intensified vs Standard HAART in Primary HIV-1
NCT01033760Phase 3Completed
- Sponsor
- ANRS
- Start
- Apr 2010
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of raltegravir, maraviroc in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ANRS. Started Apr 2010; status: completed.
02
Drugs
raltegravirmaraviroc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01033760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01033760.